Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 12, 2026 20:22 UTC |
Dodd Sheri LouiseDirector · Chief Executive Officer
|
SaleCommon Stock | 10,978 | $29.44 | $323,242.82 |
DisclosureSEC source: 0001837111-26-000007 · form4-08122026_080842.xml · nonDerivative · entry 1 Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,907 F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F2 · price: Reflects the weighted average price of 10,978 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on August 10, 2026 with sale prices ranging from $28.93 to $29.81 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 13, 2026 21:01 UTC |
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 4,631 | $24.49 | $113,403.93 |
DisclosureSEC source: 0001968559-26-000007 · form4-05132026_090558.xml · nonDerivative · entry 1 Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,188 F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F2 · price: Reflects the weighted average price of 4,631 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 11, 2026 with sale prices ranging from $23.89 to $25.42 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:31 UTC |
Asbury Valerie L.Director
|
GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001904264-26-000002 · form4-05082026_090553.xml · nonDerivative · entry 1 Asbury Valerie L. · CIK 0001904264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,343 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:31 UTC |
Huggenberger RaymondDirector
|
GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001596078-26-000002 · form4-05082026_090525.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,841 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:31 UTC |
King Laura G.Director
|
GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0002049487-26-000002 · form4-05082026_090555.xml · nonDerivative · entry 1 King Laura G. · CIK 0002049487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,569 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:30 UTC |
Pearson AndreaDirector
|
GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001478345-26-000010 · form4-05082026_090522.xml · nonDerivative · entry 1 Pearson Andrea · CIK 0001478345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,373 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:29 UTC |
Shafer David BrentDirector
|
GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001728374-26-000002 · form4-05082026_090541.xml · nonDerivative · entry 1 Shafer David Brent · CIK 0001728374 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,343 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:29 UTC |
Volkart Carmen BDirector
|
GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001282953-26-000002 · form4-05082026_090506.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,219 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:28 UTC |
Washington Boyd VindellDirector
|
GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001994641-26-000002 · form4-05082026_090535.xml · nonDerivative · entry 1 Washington Boyd Vindell · CIK 0001994641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,768 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:28 UTC |
BURKE WILLIAM WDirector
|
GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001200612-26-000002 · form4-05082026_090504.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,041 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:13 UTC |
Pearson AndreaDirector
|
GrantCommon Stock | 852 | $0.00 | $0.00 |
DisclosureSEC source: 0001478345-26-000008 · form4-03112026_080348.xml · nonDerivative · entry 1 Pearson Andrea · CIK 0001478345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 852 F1 · shares: Represents restricted stock units that will vest in full on the date of the Company's 2026 annual meeting of stockholders. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:57 UTC |
Dodd Sheri LouiseDirector · Chief Executive Officer
|
SaleCommon Stock | 10,993 | $28.94 | $318,144.02 |
DisclosureSEC source: 0001837111-26-000005 · form4-02262026_090218.xml · nonDerivative · entry 1 Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,885 F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F2 · price: Reflects the weighted average price of 10,993 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:56 UTC |
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 7,701 | $28.94 | $222,880.03 |
DisclosureSEC source: 0001968559-26-000005 · form4-02262026_090201.xml · nonDerivative · entry 1 Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,819 F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F2 · price: Reflects the weighted average price of 7,701 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:55 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 6,246 | $28.94 | $180,764.24 |
DisclosureSEC source: 0001857721-26-000007 · form4-02262026_090232.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,581 F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F2 · price: Reflects the weighted average price of 6,246 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:32 UTC |
Dodd Sheri LouiseDirector · Chief Executive Officer
|
SaleCommon Stock | 537 | $28.69 | $15,406.05 |
DisclosureSEC source: 0001837111-26-000004 · form4-02242026_100251.xml · nonDerivative · entry 4 Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,878 F3 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F5 · price: Reflects the weighted average price of 537 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:32 UTC |
Dodd Sheri LouiseDirector · Chief Executive Officer
|
SaleCommon Stock | 14,703 | $28.28 | $415,839.07 |
DisclosureSEC source: 0001837111-26-000004 · form4-02242026_100251.xml · nonDerivative · entry 3 Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,415 F3 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F4 · price: Reflects the weighted average price of 14,703 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:33 UTC |
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 196 | $28.69 | $5,623.08 |
DisclosureSEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 5 Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,520 F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F6 · price: Reflects the weighted average price of 196 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:33 UTC |
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 5,322 | $28.28 | $150,520.53 |
DisclosureSEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 4 Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,716 F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F5 · price: Reflects the weighted average price of 5,322 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:32 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 160 | $28.69 | $4,590.29 |
DisclosureSEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 5 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,827 F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F6 · price: Reflects the weighted average price of 160 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:32 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 4,279 | $28.28 | $121,021.67 |
DisclosureSEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 4 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,987 F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units. F5 · price: Reflects the weighted average price of 4,279 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:32 UTC |
Dodd Sheri LouiseDirector · Chief Executive Officer
|
GrantCommon Stock | 28,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001837111-26-000004 · form4-02242026_100251.xml · nonDerivative · entry 2 Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,118 F2 · shares: On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 28,216 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:32 UTC |
Dodd Sheri LouiseDirector · Chief Executive Officer
|
GrantCommon Stock | 19,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001837111-26-000004 · form4-02242026_100251.xml · nonDerivative · entry 1 Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,902 F1 · shares: On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 19,751 PSUs. Those earned PSUs vested on February 20, 2026. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:33 UTC |
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 15,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 3 Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,038 F3 · shares: On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 15,575 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:33 UTC |
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 6,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 2 Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,463 F2 · shares: On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 6,765 PSUs. Those earned PSUs vested on February 20, 2026. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:33 UTC |
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 3,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 1 Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,698 F1 · shares: On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 3,579 PSUs. Those earned PSUs vested on February 20, 2026. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:32 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantCommon Stock | 7,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 3 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,266 F3 · shares: On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 7,123 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:32 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantCommon Stock | 4,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 2 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,143 F2 · shares: On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 4,058 PSUs. Those earned PSUs vested on February 20, 2026. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:32 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantCommon Stock | 3,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,085 F1 · shares: On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 3,490 PSUs. Those earned PSUs vested on February 20, 2026. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:47 UTC |
Dodd Sheri LouiseDirector · Chief Executive Officer
|
GrantCommon Stock | 48,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001837111-26-000002 · form4-02232026_090243.xml · nonDerivative · entry 1 Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,151 F1 · shares: Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:47 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantCommon Stock | 6,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001857721-26-000004 · form4-02232026_090210.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,595 F1 · shares: Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:46 UTC |
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 23,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001968559-26-000002 · form4-02232026_090215.xml · nonDerivative · entry 1 Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,119 F1 · shares: Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:53 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 5,139 | $28.85 | $148,260.15 |
DisclosureSEC source: 0001857721-26-000002 · form4-01062026_090117.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,401 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 9/11/2025. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 22:03 UTC |
Dodd Sheri LouiseDirector · Chief Executive Officer
|
SaleCommon Stock | 7,762 | $12.36 | $95,907.27 |
DisclosureSEC source: 0001415889-25-021513 · form4-08122025_100828.xml · nonDerivative · entry 1 Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,479 F1 · shares: These shares were sold to cover taxes associated with the settlement of restricted stock units. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:26 UTC |
Birkemeyer Elaine M.Chief Financial Officer
|
SaleCommon Stock | 2,921 | $9.94 | $29,037.37 |
DisclosureSEC source: 0001437749-25-016924 · rdgdoc.xml · nonDerivative · entry 1 Birkemeyer Elaine M. · CIK 0001968559 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,111 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 2,921 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 12, 2025 with sale prices ranging from $9.935 to $9.945 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2025 Filed May 9, 2025 20:28 UTC |
BURKE WILLIAM WDirector
|
SaleCommon Stock | 3,300 | $9.67 | $31,911.00 |
DisclosureSEC source: 0001437749-25-015802 · rdgdoc.xml · nonDerivative · entry 2 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,520 F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 05-28-2024 F3 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:34 UTC |
Dodd Sheri LouiseDirector · Chief Executive Officer
|
SaleCommon Stock | 3,149 | $9.83 | $30,954.67 |
DisclosureSEC source: 0001437749-25-016138 · rdgdoc.xml · nonDerivative · entry 1 Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,241 F1 · shares: These shares were sold to cover taxes associated with the settlement of restricted stock units. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:28 UTC |
BURKE WILLIAM WDirector
|
GrantCommon Stock | 16,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015802 · rdgdoc.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,820 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:28 UTC |
Asbury Valerie L.Director
|
GrantCommon Stock | 16,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015801 · rdgdoc.xml · nonDerivative · entry 1 Asbury Valerie L. · CIK 0001904264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,822 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:27 UTC |
King Laura G.Director
|
GrantCommon Stock | 16,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015798 · rdgdoc.xml · nonDerivative · entry 1 King Laura G. · CIK 0002049487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,048 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:27 UTC |
Huggenberger RaymondDirector
|
GrantCommon Stock | 16,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015800 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,320 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:26 UTC |
Shafer David BrentDirector
|
GrantCommon Stock | 16,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015796 · rdgdoc.xml · nonDerivative · entry 1 Shafer David Brent · CIK 0001728374 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,822 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:26 UTC |
Volkart Carmen BDirector
|
GrantCommon Stock | 16,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015795 · rdgdoc.xml · nonDerivative · entry 1 Volkart Carmen B · CIK 0001282953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,698 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:25 UTC |
Washington Boyd VindellDirector
|
GrantCommon Stock | 16,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015794 · rdgdoc.xml · nonDerivative · entry 1 Washington Boyd Vindell · CIK 0001994641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,247 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:20 UTC |
REUVERS DANIEL L.Director
|
GiftCommon Stock | 68,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-007530 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 68,162 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:20 UTC |
REUVERS DANIEL L.Director
|
GiftCommon Stock | 68,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-007530 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,442 Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:29 UTC |
Birkemeyer Elaine M.Chief Financial Officer
|
SaleCommon Stock | 2,066 | $14.51 | $29,979.52 |
DisclosureSEC source: 0001437749-25-005486 · rdgdoc.xml · nonDerivative · entry 1 Birkemeyer Elaine M. · CIK 0001968559 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,032 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 2,066 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.50 to $14.52 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:28 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 6,468 | $14.40 | $93,159.90 |
DisclosureSEC source: 0001437749-25-005484 · rdgdoc.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,540 F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F2 · price: Reflects the weighted average price of 6,468 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.40 to $14.41 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:27 UTC |
REUVERS DANIEL L.Director
|
SaleCommon Stock | 28,338 | $14.18 | $401,849.84 |
DisclosureSEC source: 0001437749-25-005481 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,604 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 28,338 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.09 to $14.49 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2025 Filed Feb 24, 2025 23:24 UTC |
REUVERS DANIEL L.Director
|
SaleCommon Stock | 10,938 | $14.55 | $159,146.81 |
DisclosureSEC source: 0001437749-25-004938 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 242,942 F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 F3 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F4 · price: Reflects the weighted average price of 10,938 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $14.50 to $14.61 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2025 Filed Feb 24, 2025 23:23 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
SaleCommon Stock | 4,830 | $14.65 | $70,752.74 |
DisclosureSEC source: 0001437749-25-004936 · rdgdoc.xml · nonDerivative · entry 4 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,008 F5 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F6 · price: Reflects the weighted average price of 4,830 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $14.4301 to $14.82 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.